Skip to main content
. 2020 Sep 28;12(10):619. doi: 10.3390/toxins12100619

Table 3.

Modulation of intestinal epithelial cells (physical barrier) induced by mycotoxins.

Model Dose/Administration Route Exposure Time Technique Damage References
Aflatoxin
Caco-2 cells AFB1: 1–50 μM 24 h Alamar blue assay Decrease cell viability [77]
Caco-2 cells AFB1: 0.01–1 μg/mL
AFM1: 0.01–1 μg/mL
24, 48, 72 h MTT assay AFB1: decrease cell viability
AFM1: decrease cell viability
[78]
Caco-2 cells AFB1: 4 μg/mL
AFM1: 4 μg/mL
24 h MTT assay AFB1: decrease cell viability
AFM1: decrease cell viability
[79]
Caco-2 cells AFM1: 0.0005–4 μg/mL 48 h RNA-Seq,
CCK-8 assay,
Flow cytometry analysis
No effect on cell viability
Induce cell cycle arrest
[80]
Caco-2/HT29-MTX cells AFM1: 0.05, 4 μg/mL 48 h CCK-8 assay Decrease cell viability [43]
Ochratoxin A
Caco-2/HT29-MTX cells OTA: 0.05, 4 μg/mL 48 h CCK-8 assay Decrease cell viability [43]
IPEC-J2 Cells OTA: 0.5–32 μM 6, 12, 24 h MTT assay Decrease cell viability [81]
Caco-2 cells OTA: 0.1–30 μM 24 h RNA-Seq,
CCK-8 assay,
Flow cytometry analysis
Decrease cell viability
Arrest cell cycle in G2/M phase
Induce apoptosis
[82]
Caco-2 cells OTA: 0.0005–4 μg/mL 48 h RNA-Seq,
Flow cytometry analysis
Induce cell apoptosis [83]
Caco-2 cells OTA: 0.5–160 μM 48 h MTS assay Decrease cell viability [84]
Deoxynivalenol
Caco-2 cells DON: 0.25–30 μM 48 h MTS assay Decrease cell viability [84]
HT-29 cells DON: 125–2000 ng/mL 24 h Western blot analysis Induce cell apoptosis [24]
IEC-6 cells DON: 0.5–80 μM 24 h Propidium iodide staining Induce cell apoptosis [85]
IPEC-J2 Cells DON: 200, 2000 ng/mL 24, 48, 72 h BrdU incorporation assay,
Western blot analysis
Decrease cell viability
Induce cell apoptosis
[86]
IPEC-1 cells, IPEC-J2 Cells DON: 100–4000 ng/mL 24, 48, 72 h MTT assay Decrease cell viability [87]
IPEC-J2 Cells DON: 1–20 μg/mL 72 h Flow cytometry analysis Decrease cell viability
Induce cell apoptosis
[88]
Zearalenone
IPEC-J2 Cells ZEN: 40 μM 24 h CCK-8 assay,
Flow cytometry analysis,
RNA-Seq
Decrease cell viability
Arrest cell cycle in the G2/M phase
[89]
IPEC-J2 cells ZEN: 6, 8 μg/mL 12–48 h MTT assay,
PCR
Decrease cell viability
Induce cell apoptosis
[90]
IPEC-1 cells ZEN: 0.1–100 μM 24 h XTT assay,
Microarray assay
Decrease cell viability [91]
HCT116 cells ZEN: 0–320 μM 48 h Methylene blue staining assay Increase cell viability at very low concentrations, decrease cell viability at high concentrations [92]
Fumonisin B1
HT-29 cells FB1: 1.1–69 μM 72 h MTT assay Decrease cell viability [93]
Patulin
Caco-2 cells PAT: 1–150 μM 24 h MTT assay Decrease cell viability [94]
Caco-2 cells PAT: 0.7–18 μM 24 h MTT assay Decrease cell viability [95]
HCT116 cells PAT: 5–25 μM 24 h FDA assay,
Western blot analysis
Decrease cell viability
Induce cell apoptosis
[96]
HCT116 cells PAT: 1.25–20 μM 1–4 days, 24 h MTT assay,
Western blot analysis
Decrease cell viability
Induce apoptotic cells death
[97]
Citrinin
HCT116 cells CTN: 150 μM 24 h MTT assay Decrease cell viability [98]